HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

John A Carver Selected Research

Cysteine (L-Cysteine)

1/2021Native disulphide-linked dimers facilitate amyloid fibril formation by bovine milk αS2-casein.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


John A Carver Research Topics

Disease

14Cataract (Cataracts)
01/2021 - 09/2002
12Alzheimer Disease (Alzheimer's Disease)
10/2022 - 01/2010
7Parkinson Disease (Parkinson's Disease)
04/2021 - 07/2004
5Neurodegenerative Diseases (Neurodegenerative Disease)
01/2017 - 07/2004
5Amyloid Plaque
02/2016 - 07/2004
5Proteostasis Deficiencies
11/2014 - 03/2008
2HIV Infections (HIV Infection)
10/2022 - 09/2014
2Virus Diseases (Viral Diseases)
10/2022 - 09/2014
2Amyloidosis
01/2021 - 06/2011
2Synucleinopathies
10/2016 - 09/2014
2AIDS-Related Complex (ARC)
03/2015 - 06/2014
1Inflammation (Inflammations)
01/2023
1Neuromuscular Diseases (Neuromuscular Disease)
01/2017
1Infections
02/2015
1Carcinoma (Carcinomatosis)
09/2014
1Neuritis (Polyneuritis)
09/2014
1Pheochromocytoma
09/2014
1Dementia (Dementias)
09/2014
1Disease Progression
08/2011
1Prion Diseases (Transmissible Spongiform Encephalopathies)
11/2010
1Macular Degeneration (Age-Related Maculopathy)
09/2010
1Huntington Disease (Huntington's Disease)
06/2010
1Spinocerebellar Ataxias (Spinocerebellar Ataxia)
06/2010
1Creutzfeldt-Jakob Syndrome (Creutzfeldt-Jakob Disease)
10/2007
1Desmin-Related Myofibrillar Myopathy
02/2005

Drug/Important Bio-Agent (IBA)

24Amyloid (Amyloid Fibrils)IBA
10/2022 - 01/2004
21Proteins (Proteins, Gene)FDA Link
01/2019 - 01/2004
19Crystallins (Crystallin)IBA
01/2021 - 09/2002
8Molecular Chaperones (Chaperone, Molecular)IBA
10/2022 - 07/2004
5Peptides (Polypeptides)IBA
01/2020 - 01/2010
5Small Heat-Shock ProteinsIBA
02/2015 - 03/2008
4Protein AggregatesIBA
01/2018 - 06/2010
4SynucleinsIBA
10/2016 - 05/2012
3Caseins (Casein)FDA Link
02/2016 - 12/2005
3Amyloid beta-PeptidesIBA
12/2013 - 09/2009
3alpha-SynucleinIBA
03/2010 - 07/2004
2AcidsIBA
10/2022 - 09/2014
2N-acetyltalosaminuronic acid (NAT)IBA
01/2021 - 02/2005
2Amino AcidsFDA Link
03/2015 - 06/2014
1Acyl Coenzyme A (Acyl CoA)IBA
01/2023
1EnzymesIBA
01/2023
1Ion Channels (Ion Channel)IBA
01/2023
1prostatic acid phosphataseIBA
10/2022
1ClusterinIBA
10/2022
1SaltsIBA
11/2021
1Lysine (L-Lysine)FDA Link
11/2021
1Dopamine (Intropin)FDA LinkGeneric
04/2021
1Neurotransmitter Agents (Neurotransmitter)IBA
04/2021
1ProteomeIBA
01/2021
1Cysteine (L-Cysteine)FDA Link
01/2021
1DisulfidesIBA
01/2019
1Protein SIBA
01/2019
1Phospholipids (Phosphatides)FDA LinkGeneric
02/2016
1SolutionsIBA
02/2016
1Adenosine Monophosphate (AMP)IBA
02/2016
1Antimicrobial Cationic PeptidesIBA
11/2015
1RibonucleotidesIBA
03/2015
1RNA (Ribonucleic Acid)IBA
03/2015
1Hemin (Panhematin)FDA Link
11/2014
1Phosphoric Monoester Hydrolases (Phosphatases)IBA
09/2014
1Peptide FragmentsIBA
09/2014
1Gallic AcidIBA
12/2013
1Methionine (L-Methionine)FDA Link
04/2012
114-3-3 Proteins (14-3-3 Protein)IBA
08/2011
1PhosphoserineIBA
08/2011
1Oxygen (Dioxygen)IBA
09/2010
1polyglutamineIBA
06/2010
1Adenosine Triphosphate (ATP)IBA
03/2010
1Amyloidogenic ProteinsIBA
01/2010
1Recombinant ProteinsIBA
11/2009
1PolyphenolsIBA
09/2009

Therapy/Procedure

1Therapeutics
11/2014